• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research.直觉在人体研究风险/收益决策中的作用
Account Res. 2017;24(1):1-29. doi: 10.1080/08989621.2016.1198978. Epub 2016 Jun 13.
2
Standards of evidence for institutional review board decision-making.机构审查委员会决策的证据标准。
Account Res. 2021 Oct;28(7):428-455. doi: 10.1080/08989621.2020.1855149. Epub 2020 Dec 8.
3
Should the Decisions of Institutional Review Boards Be Consistent?机构审查委员会的决定应该保持一致吗?
Ethics Hum Res. 2019 Jul;41(4):2-14. doi: 10.1002/eahr.500022.
4
Confidence of IRB/REC Members in Their Assessments of Human Research Risk: A Study of IRB/REC Decision Making in Action.机构审查委员会/伦理审查委员会成员对其人类研究风险评估的信心:一项关于机构审查委员会/伦理审查委员会实际决策的研究
J Empir Res Hum Res Ethics. 2017 Jul;12(3):140-149. doi: 10.1177/1556264617710386. Epub 2017 May 30.
5
US IRBs confronting research in the developing world.美国机构伦理审查委员会在发展中国家面临的研究挑战。
Dev World Bioeth. 2012 Aug;12(2):63-73. doi: 10.1111/j.1471-8847.2012.00324.x. Epub 2012 Apr 20.
6
Uncertainty about effects is a key factor influencing institutional review boards' approval of clinical studies.效应的不确定性是影响机构审查委员会批准临床研究的关键因素。
Ann Epidemiol. 2014 Oct;24(10):734-40. doi: 10.1016/j.annepidem.2014.06.100. Epub 2014 Jul 10.
7
How do institutional review boards apply the federal risk and benefit standards for pediatric research?机构审查委员会如何应用联邦关于儿科研究的风险和收益标准?
JAMA. 2004 Jan 28;291(4):476-82. doi: 10.1001/jama.291.4.476.
8
Understanding institutional review boards: practical guidance to the IRB review process.了解机构审查委员会:IRB审查过程实用指南
Nutr Clin Pract. 2007 Dec;22(6):618-28. doi: 10.1177/0115426507022006618.
9
Steps toward a System of IRB Precedent: Piloting Approaches to Summarizing IRB Decisions for Future Use.迈向 IRB 判例制度的步骤:为未来使用而总结 IRB 决策的方法初探。
Ethics Hum Res. 2021 Nov;43(6):2-18. doi: 10.1002/eahr.500106. Epub 2021 Oct 21.
10
Operational Characteristics of Institutional Review Boards (IRBs) in the United States.美国机构审查委员会(IRB)的运作特点
AJOB Empir Bioeth. 2019 Oct-Dec;10(4):276-286. doi: 10.1080/23294515.2019.1670276. Epub 2019 Oct 16.

引用本文的文献

1
Standards of evidence for institutional review board decision-making.机构审查委员会决策的证据标准。
Account Res. 2021 Oct;28(7):428-455. doi: 10.1080/08989621.2020.1855149. Epub 2020 Dec 8.
2
Efficacy, safety and cost-effectiveness of hydroxychloroquine in children with COVID-19: A call for evidence.羟氯喹啉治疗儿童新冠病毒肺炎的疗效、安全性及成本效益:证据呼吁
Acta Paediatr. 2020 Sep;109(9):1711-1712. doi: 10.1111/apa.15373. Epub 2020 Jun 3.
3
Risk Assessment of Medical Study Procedures in the Documents Submitted to a Research Ethics Committee.向研究伦理委员会提交的医学研究文件中的研究程序风险评估。
J Empir Res Hum Res Ethics. 2020 Dec;15(5):396-406. doi: 10.1177/1556264620903563. Epub 2020 Feb 8.
4
Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment.HIV 治愈研究中断治疗试验的伦理学:解决风险/效益评估的难题。
J Med Ethics. 2018 Apr;44(4):270-276. doi: 10.1136/medethics-2017-104433. Epub 2017 Nov 10.
5
Minimal Risk in Pediatric Research: A Philosophical Review and Reconsideration.儿科研究中的最小风险:哲学审视与反思
Account Res. 2017;24(7):407-432. doi: 10.1080/08989621.2017.1363650. Epub 2017 Aug 4.

本文引用的文献

1
Assessing risk/benefit for trials using preclinical evidence: a proposal.利用临床前证据评估试验的风险/益处:一项提议。
J Med Ethics. 2016 Jan;42(1):50-3. doi: 10.1136/medethics-2015-102882. Epub 2015 Oct 13.
2
Neural systems involved in moral judgment and moral action.参与道德判断和道德行为的神经系统。
J Neurosci. 2014 Aug 6;34(32):10459-61. doi: 10.1523/JNEUROSCI.2005-14.2014.
3
Decision theory and the evaluation of risks and benefits of clinical trials.决策理论与临床试验风险和获益的评估。
Drug Discov Today. 2012 Dec;17(23-24):1263-9. doi: 10.1016/j.drudis.2012.07.005. Epub 2012 Jul 20.
4
Liberating reason from the passions: overriding intuitionist moral judgments through emotion reappraisal.从激情中解放理性:通过情绪再评估来克服直觉主义道德判断。
Psychol Sci. 2012 Jul 1;23(7):788-95. doi: 10.1177/0956797611434747. Epub 2012 May 25.
5
The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methods.研究伦理委员会的风险效益任务:对当前方法的评估以及需要纳入决策研究方法。
BMC Med Ethics. 2012 Apr 20;13:6. doi: 10.1186/1472-6939-13-6.
6
Is there an objective way to compare research risks?是否有客观的方法来比较研究风险?
J Med Ethics. 2012 Jul;38(7):423-7. doi: 10.1136/medethics-2011-100194. Epub 2012 Feb 25.
7
Limits on risks for healthy volunteers in biomedical research.生物医学研究中健康志愿者风险的限制。
Theor Med Bioeth. 2012 Apr;33(2):137-49. doi: 10.1007/s11017-011-9201-1.
8
Burdens on research imposed by institutional review boards: the state of the evidence and its implications for regulatory reform.机构审查委员会给研究带来的负担:证据现状及其对监管改革的影响。
Milbank Q. 2011 Dec;89(4):599-627. doi: 10.1111/j.1468-0009.2011.00644.x.
9
Is payment a benefit?付款是一种福利吗?
Bioethics. 2013 Feb;27(2):105-16. doi: 10.1111/j.1467-8519.2011.01892.x. Epub 2011 Jul 4.
10
A framework for risk-benefit evaluations in biomedical research.生物医学研究中风险-效益评估的框架。
Kennedy Inst Ethics J. 2011 Jun;21(2):141-79. doi: 10.1353/ken.2011.0007.

直觉在人体研究风险/收益决策中的作用

The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research.

作者信息

Resnik David B

机构信息

a National Institute of Environmental Health Sciences, National Institutes of Health , Research Triangle Park , North Carolina , USA.

出版信息

Account Res. 2017;24(1):1-29. doi: 10.1080/08989621.2016.1198978. Epub 2016 Jun 13.

DOI:10.1080/08989621.2016.1198978
PMID:27294429
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5126729/
Abstract

One of the key principles of ethical research involving human subjects is that the risks of research to should be acceptable in relation to expected benefits. Institutional review board (IRB) members often rely on intuition to make risk/benefit decisions concerning proposed human studies. Some have objected to using intuition to make these decisions because intuition is unreliable and biased and lacks transparency. In this article, I examine the role of intuition in IRB risk/benefit decision-making and argue that there are practical and philosophical limits to our ability to reduce our reliance on intuition in this process. The fact that IRB risk/benefit decision-making involves intuition need not imply that it is hopelessly subjective or biased, however, since there are strategies that IRBs can employ to improve their decisions, such as using empirical data to estimate the probability of potential harms and benefits, developing classification systems to guide the evaluation of harms and benefits, and engaging in moral reasoning concerning the acceptability of risks.

摘要

涉及人类受试者的伦理研究的关键原则之一是,相对于预期收益而言,研究的风险应该是可接受的。机构审查委员会(IRB)成员在对拟议的人体研究进行风险/收益决策时,常常依靠直觉。一些人反对使用直觉来做出这些决策,因为直觉不可靠、有偏见且缺乏透明度。在本文中,我审视了直觉在IRB风险/收益决策中的作用,并认为在这个过程中,我们减少对直觉依赖的能力存在实践和哲学上的局限。然而,IRB风险/收益决策涉及直觉这一事实并不意味着它必然是主观得无可救药或有偏见的,因为IRB可以采用一些策略来改进其决策,比如使用实证数据来估计潜在危害和收益的概率,开发分类系统以指导对危害和收益的评估,以及就风险的可接受性进行道德推理。